Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 47

Страница 1 из 5

Why children differ in motivation to learn: Insights from over 13,000 twins from 6 countries
Kovas, Yulia V., Boivin, Michel, Petrill, Stephen A., Plomin, Robert, Malykh, Sergey B., Spinath, Frank, Murayama, Kou, Ando, Juko, Bogdanova, Olga Y., Yamagata, Shinji, Shikishima, Chizuru, Spinath, Birgit, Thompson, Lee A., Tikhomirova, Tatiana N., Tosto, Maria Grazia, Tremblay, Richard E., Vitaro, Frank, Garon-Carrier, Gabrielle, Brendgen, Mara, Dionne, Ginette, Forget-Dubois, Nadine, Galazhinsky, Eduard V., Gottschling, Juliana, Guay, Frederic, Lemelin, Jean-Pascal, Logan, Jessica A. R.
Genetic Divergence of Far-Eastern Dace Species Belonging to the Genus Tribolodon (Pisces, Cyprinidae) and Closely Related Taxa
Kartavtsev, Yuri Fedorovich, Sviridov, Vladimir Vladimirovich, Hanzawa, Naoto Yamagata
Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
Kiseleva I.
Background. Currently, two genetic lineages of influenza B virus, B/Victoria and B/Yamagata
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
Rudenko L.
/Victoria or B/ Yamagata lineage virus, or quadrivalent LAIV (containing both B lineages), or placebo. They were
HUMORAL IMMUNITY IN ELDERLY PERSONS VACCINATED AGAINST INFLUENZA SHORTLY BEFORE CANCELLATION OF COVID-19 PANDEMIC; [СОСТОЯНИЕ ГУМОРАЛЬНОГО ИММУНИТЕТА У ПОЖИЛЫХ, ПРИВИТЫХ ПРОТИВ ГРИППА НАКАНУНЕ ОТМЕНЫ СТАТУСА ПАНДЕМИИ COVID-19]
Iushkova S.V., Kostinov M.P., Gladkova L.S., Kameleva A.A., Kachnova A.S., Kostinova A.M., Solovyeva I.L., Andreeva N.P., Dagil Yu.A., Nastaeva N.Yu., Kryukova N.O., Saifutdinov K.A., Linok A.V., Khrapunova I.A., Raicic S.R., Loktionova M.N., Polishchuk V.B., Albahansa M.Y.
; for the B/Yamagata strain, 8.6 (log2 3.11±0.54) versus 24.1 (log2 4.59±0.79). The GMT level for the B
Monoclonal antibodies to hemagglutinin of influenza B viruses victoria evolutionary lineage
Sorokln E.V.
with heterologous influenza viruses of B/Yamagata lineage, seasonal and potentially pandemic influenza A viruses
Cerium dioxide nanoparticles increase immunogenicity of the influenza vaccine
Zholobak, Nadezhda M., Shcherbakov, Alexander B., Shydlovska, Olga A., Spivak, Mykola Ya., Radchenko, Larysa V., Marinin, Andrey I., Ivanova, Olga S., Baranchikov, Alexander E., Ivanov, Vladimir K., Mironenko, Alla P.
strain B/Yamagata. For the low immunogenic influenza B virus, the rise in antibody titers (GMT/IF) was 24
2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: Results from the Global Influenza Hospital Surveillance Network
Puig-Barberà J.
%) for influenza A(H3N2), and 43% (95% CI, 17% to 60%) for influenza B/Yamagata. IVE estimates were similar
Summary of influenza and other respiratory viruses detected and characterized in Russia during 2017–2018 season
Sominina A.A.
, of which 39.3% were influenza A(H1N1)pdm09 viruses, 29.6% were A(H3N2) and 31.1% influenza B (Yamagata
Safety, immunogenicity, and protective efficacy of a chimeric a/b live attenuated influenza vaccine in a mouse model
Stepanova E.
vaccines are composed of three or four strains: A/H1N1, A/H3N2, and B (Victoria and Yamagata lineages

Страница 1 из 5

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core